CAS OpenIR  > 膜生物学国家重点实验室
Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells
Source PublicationTransplant Immunology
2011
Volume25Issue:4Pages:173-179
Duan KZ; Zhang BJ; Zhang WY; Zhao YA; Qu YY; Sun CM; Zhao Y
Document Type期刊论文
Identifierhttp://ir.ioz.ac.cn/handle/000000/10552
Collection膜生物学国家重点实验室
Recommended Citation
GB/T 7714
Duan KZ,Zhang BJ,Zhang WY,et al. Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells[J]. Transplant Immunology,2011,25(4):173-179.
APA Duan KZ.,Zhang BJ.,Zhang WY.,Zhao YA.,Qu YY.,...&Zhao Y.(2011).Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells.Transplant Immunology,25(4),173-179.
MLA Duan KZ,et al."Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells".Transplant Immunology 25.4(2011):173-179.
Files in This Item: Download All
File Name/Size DocType Version Access License
211-Efficient periph(982KB) 开放获取ODC PDDLView Download
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Duan KZ]'s Articles
[Zhang BJ]'s Articles
[Zhang WY]'s Articles
Baidu academic
Similar articles in Baidu academic
[Duan KZ]'s Articles
[Zhang BJ]'s Articles
[Zhang WY]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Duan KZ]'s Articles
[Zhang BJ]'s Articles
[Zhang WY]'s Articles
Terms of Use
No data!
Social Bookmark/Share
File name: 211-Efficient peripheral construction of funct.pdf
Format: Adobe PDF
This file does not support browsing at this time
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.